Merajver SD - Search Results

1

Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Bao L, Gorin MA, Zhang M, Ventura AC, Pomerantz WC, Merajver SD, Teknos TN, Mapp AK, Pan Q. Bao L, et al. Among authors: merajver sd. Cancer Res. 2009 Jul 15;69(14):5829-34. doi: 10.1158/0008-5472.CAN-08-3465. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567682 Free PMC article.

2

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Cancer Res. 2000 Oct 15;60(20):5832-8. Cancer Res. 2000. PMID: 11059780

3

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Neoplasia. 2000 Sep-Oct;2(5):418-25. doi: 10.1038/sj.neo.7900115. Neoplasia. 2000. PMID: 11191108 Free PMC article.

4

The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.

Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. Cox C, et al. Among authors: merajver sd. Laryngoscope. 2001 Apr;111(4 Pt 1):696-701. doi: 10.1097/00005537-200104000-00024. Laryngoscope. 2001. PMID: 11359142

5

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Oncogene. 2002 May 9;21(20):3172-80. doi: 10.1038/sj.onc.1205462. Oncogene. 2002. PMID: 12082632

6

Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Clin Exp Metastasis. 2002;19(4):301-11. doi: 10.1023/a:1015518114931. Clin Exp Metastasis. 2002. PMID: 12090470 Free article.

7

Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Neoplasia. 2002 Sep-Oct;4(5):373-9. doi: 10.1038/sj.neo.7900258. Neoplasia. 2002. PMID: 12192595 Free PMC article.

8

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Pan Q, et al. Among authors: merajver sd. Cancer Res. 2002 Sep 1;62(17):4854-9. Cancer Res. 2002. PMID: 12208730

9

Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Mol Cancer Ther. 2002 Jun;1(8):575-83. Mol Cancer Ther. 2002. PMID: 12479217

10

Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.

Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. Redman BG, et al. Among authors: merajver sd. Clin Cancer Res. 2003 May;9(5):1666-72. Clin Cancer Res. 2003. PMID: 12738719 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters